1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Texas >
  6. US BioTek Laboratories Acquires RealTime

M&A Deal Summary

US BioTek Laboratories Acquires RealTime

On March 19, 2024, US BioTek Laboratories acquired life science company RealTime

Acquisition Highlights
  • This is US BioTek Laboratories’ 1st transaction in the Life Science sector.
  • This is US BioTek Laboratories’ 1st transaction in the United States.
  • This is US BioTek Laboratories’ 1st transaction in Texas.

M&A Deal Summary
Date 2024-03-19
Target RealTime
Sector Life Science
Buyer(s) US BioTek Laboratories
Deal Type Add-on Acquisition

Target

RealTime

Lewisville, Texas, United States
RealTime is a CAP and CLIA-accredited clinical and environmental diagnostic laboratory that specializes in testing for and identifying hazardous toxins from mold (mycotoxins) in humans, houses, and animals, as well as infectious diseases. RealTime was formed in 2005 and is based in Lewisville, Texas.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

US BioTek Laboratories

Shoreline, Washington, United States
Category Company
Sector Test/Measurement Equipment
DESCRIPTION

US BioTek Laboratories is a provider of specialty testing services for food-related allergies and intolerances. US BioTek is a Clinical Laboratory Improvement Amendments (CLIA) accredited testing facility that provides a variety of immunology and chemistry profiles to clinicians worldwide. US BioTek Laboratories is based in Shoreline, Washington.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Texas M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2024 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal